Investigational Drug Services IDS Pharmacy Charlene Chiu Pharm

  • Slides: 32
Download presentation
Investigational Drug Services (IDS) Pharmacy Charlene Chiu, Pharm. D. Clinical Pharmacist | PIC –

Investigational Drug Services (IDS) Pharmacy Charlene Chiu, Pharm. D. Clinical Pharmacist | PIC – USC IDS Pharmacy June 6 th, 2019

Overview • What is an IDS Pharmacy? • About Us • Role of IDS

Overview • What is an IDS Pharmacy? • About Us • Role of IDS in Clinical Trials • Workflow for New Studies • Industry • Consortium • Investigator Initiated • Common Pitfalls & Limitations 2

What is USC IDS Pharmacy? • Retail Licensed Pharmacy dedicated for research • Approximately

What is USC IDS Pharmacy? • Retail Licensed Pharmacy dedicated for research • Approximately ~300 studies • Study Sites • LAC+USC Medical Center • Norris Cancer Hospital • Keck Outpatient – Healthcare Clinics • Beverly Hills – USC Norris Westside Cancer Center • Satellite Sites • Keck Hospital • Newport Beach - USC Oncology/Hematology Infusion Center (OCOH) 3

About Us Edward Hill Pharmacy Courier Charlene Chiu, Pharm. D. David Bateshansky, Pharm. D.

About Us Edward Hill Pharmacy Courier Charlene Chiu, Pharm. D. David Bateshansky, Pharm. D. IDS Pharmacist - Norris IDS Pharmacist Travis Rock Pharmacy Technician 4

Upcoming for December Current Location: Keck HC 3 1516 San Pablo St. Suite 3403

Upcoming for December Current Location: Keck HC 3 1516 San Pablo St. Suite 3403 (4 th floor) Los Angeles, CA 90033 Permanent Location: Norris Cancer Center currently under construction 1441 Eastlake Ave (2 nd Floor), Los Angeles CA 90033 Hours of Operation: 8: 00 AM to 4: 30 PM 5

IDS Work Space – HC 3 6

IDS Work Space – HC 3 6

IDS Work Space – HC 3 7

IDS Work Space – HC 3 7

Storage – Refrigerator 8

Storage – Refrigerator 8

Storage – Ambient Temperature 9

Storage – Ambient Temperature 9

Role of IDS in Clinical Trials • Preliminary • Site Qualification Visit • IRB,

Role of IDS in Clinical Trials • Preliminary • Site Qualification Visit • IRB, CIC Review - Feasibility • Protocol Review / Scope of Service for IIT • Regulatory Compliance • Drug Procurement / Storage • Prescription Processing / Dispensing • Drug Destruction / Return • Sponsored Visits 10

Regulatory Compliance • Good Clinical Practice • Human Subjects Research • Board of Pharmacy,

Regulatory Compliance • Good Clinical Practice • Human Subjects Research • Board of Pharmacy, DEA Licensure • Protocol and Amendment Training • Unblinded Staff 11

Drug Procurement / Storage • Drug Requests – Initial & Resupply • Auto-Resupply •

Drug Procurement / Storage • Drug Requests – Initial & Resupply • Auto-Resupply • Form • Electronic request – NCI, DAIDS • Drug Receipt • Temp. Tale documentation • Temperature Excursion Reporting • Drug Accountability Record Forms • Interactive Web Response System 12

Drug Procurement / Storage (cont) • Refrigerators (7) • Ambient Temperature – 20°C to

Drug Procurement / Storage (cont) • Refrigerators (7) • Ambient Temperature – 20°C to 25°C • Freezer • -20°C (-15°C to -25°C) • -80°C (-70°C to -90°C) • Temperature Monitoring • Fresh. Loc – continuous monitoring • Min/Max Thermometer (Back up) 13

Prescription Processing / Dispensing • Prescription Review for Appropriateness • Initial Enrollment • Informed

Prescription Processing / Dispensing • Prescription Review for Appropriateness • Initial Enrollment • Informed Consent • Protocol Registration • Kit allocations • Prescription Labels • Compounding Verification • IVPB – PVC (DEHP) vs non-PVC • Tubing • Filters • Maintenance of DARFs and Inventory Checks 14

Accountability – Oral Agents 15

Accountability – Oral Agents 15

Accountability – Non Oral Agents 16

Accountability – Non Oral Agents 16

Drug Destruction / Return • On-site destruction of unused and used investigational products (IP)

Drug Destruction / Return • On-site destruction of unused and used investigational products (IP) • Returns to sponsor • IP Return / Reconciliation • Responsibility of Study Coordinator (SC) to document count (CISO – Double count) • IDS will destroy used upon reconciliation by SC and Sponsor 17

Drug Destruction / Return 18

Drug Destruction / Return 18

Regulatory Visits • Site Qualification • Site Initiation Visits • Monitoring Visits • Audits

Regulatory Visits • Site Qualification • Site Initiation Visits • Monitoring Visits • Audits (Sponsor, Federal) • Close out visits • Please remind Sponsor to schedule at least 6 weeks in advance for any visits. • Will be adding an FTE to assist with SIVs 19

Workflow for New Studies 20

Workflow for New Studies 20

Industry-Sponsored Study 1. Budget – Completed by CTO • Pharmacy Fees (Fixed/Dispensing) • Drug

Industry-Sponsored Study 1. Budget – Completed by CTO • Pharmacy Fees (Fixed/Dispensing) • Drug purchases • Refer to Budget/Research Order Form 2. Site Initiation Visit • Schedule ~6 weeks in advance • Prior to enrollment, confirm IP available in IDS 21

Consortium Study • Federal/Government and University sponsored studies • National Institutes of Health (NIH)

Consortium Study • Federal/Government and University sponsored studies • National Institutes of Health (NIH) • National Cancer Institute • Budget – Mixed with or without industry support • Site Initiation Visit – Generally internal (unless sponsored by industry) 22

Investigator-Initiated Trials • Internal USC study • Budget – Need to contact IDS for

Investigator-Initiated Trials • Internal USC study • Budget – Need to contact IDS for Scope of Service Agreement • Please email idspharmacy@med. usc. edu for all IIT inquiries • Please include: PI, IRB #, and a copy of the protocol Location(s) of drug administration Number of subjects to be treated IP information (i. e. IP name, dosage form and frequency/duration of dispensation or administration • Procurement of drugs (IDS to provide or supplied by sponsor) • • • Afterwards and internal SIV or Workflow meeting 23

After the SIV… • Work on the prescription/order template & submit to IDS for

After the SIV… • Work on the prescription/order template & submit to IDS for review • Patient info (Name, MRN, DOB, Sex, Allergies, Subject ID) • Drug info (Drug name, Dose, Sig, Kit) • Prescriber info (Original Signature, Date, Name) • Misc (Delivery Location, Coordinator Contact, Protocol Name) • Come up with a workflow (new coordinator) • When a study starts screening, prospective enrollment: confirm IP in stock 24

Cycle 1 Day 1 • Order submission - Ensure it is complete with an

Cycle 1 Day 1 • Order submission - Ensure it is complete with an original signature & date by the prescriber • IDS or Keck – Fax paper order and call to confirm receipt • Norris (Ambulatory and Inpatient) - Upload paper order in Cerner • HC 3 - Upload initial order into Cerner. On day of, either fax or hand deliver final order • Include the 1 st and last signed page of ICF • Copy of protocol enrollment / randomization • Note: Paper orders for all investigationals. SOC drugs should be ordered as normal via Cerner as noninvestigational 25

Subsequent Visits • Send completed order to respective pharmacy • Include any necessary kit

Subsequent Visits • Send completed order to respective pharmacy • Include any necessary kit numbers or randomization visit information 26

Common Pitfalls & Limitations 27

Common Pitfalls & Limitations 27

Common Pitfalls & Limitations • Preliminary • SIV / MV scheduling (or not including

Common Pitfalls & Limitations • Preliminary • SIV / MV scheduling (or not including IDS) • Drugs that are supplied by sponsor vs IDS-supplied and reimbursed by sponsor • No Pharmacy Fees incorporated for IIT • During the study • No IP available for the first patient enrolled • Shipments sent to the incorrect address • Incomplete orders (not signed, dose missing, kit #s, visit reg) • Limited compounding space/availability • Drug transfer to Norris • Hours of Operation 28

Contacts Norris Health. Care Center Pharmacy Attn: Charlene Chiu, Pharm. D. (IDS) 1516 San

Contacts Norris Health. Care Center Pharmacy Attn: Charlene Chiu, Pharm. D. (IDS) 1516 San Pablo St. Suite 3403 (4 th floor) Los Angeles, CA 90033 Office (323) – 865 – 3538 | Fax (323) – 865 – 0857 Email: idspharmacy@med. usc. edu Hours of Operation: 8: 00 AM to 4: 30 PM 29

Contacts • Norris (David Bateshansky, Pharm. D) • Ambulatory Pharmacy (323 -865 -3613) •

Contacts • Norris (David Bateshansky, Pharm. D) • Ambulatory Pharmacy (323 -865 -3613) • HC 3 Pharmacy (323 -276 -3737) • Keck Hospital (323 -442 -8800) • Akiko (Hattori) Maloney, Pharm. D. • Mira Bakas, Pharm. D. 30

Former/Future Location USC IDS Pharmacy 1441 Eastlake Ave Suite 2407 Los Angeles, CA 90033

Former/Future Location USC IDS Pharmacy 1441 Eastlake Ave Suite 2407 Los Angeles, CA 90033 Permanent Move: • • Planned for December 2019 Will provide updated SOP Will provide Note To File documenting transit Update sponsors / 1572 31

Questions? 32

Questions? 32